Challenge Arises Over an F.D.A. Panel’s Approval of a Lilly Drug. Drugs (Pharmaceuticals), Lilly, Eli, & Co, United States Politics and Government, Woodcock, Janet, Medicine and Health, House of Representatives, Hinchey, Maurice D, Stupak, Bart, Food and Drug Administration